P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris

Summary

This is a randomized, multi-center, double-blinded study in subjects with moderate to severe acne vulgaris. Subjects eligible to enroll will be treated once or twice daily with 2 concentrations of a topical drug in development or a vehicle. Subjects will be treated for up to 12 weeks.

Timeline

Start

2014-11

Primary completion

2015-06

Completion

2015-08

Drugs

Indications